Role of de novo donor‐specific anti‐HLA antibodies in kidney graft failure: A case‐control study
Abstract
The role of de novo donor‐specific anti‐human leukocyte antigen (anti‐HLA) antibodies (dnDSA) within the pathways leading to graft failure remains not fully understood. We investigated 56 patients who were transplanted between 2002 and 2014 with kidney graft failure (cases), for a possible association of development of dnDSA with graft failure. The 56 patients with failed transplants were matched with 56 patients with a functioning graft at present for the variables deceased or living donor, transplant number, transplant year, recipient age and gender, donor age and gender, dialysis vintage time, transplant induction therapy. All patients had at least one serum collected 1 year before failure (in cases) or end of follow‐up (in controls). Cases and controls were very well‐matched in several baseline characteristics. Post‐transplant anti‐HLA antibodies were found in 84% of cases and only 36% of controls (P < .001), with 54% of cases and 16% of controls (P < .001) having dnDSA at time of detection. Chronic active antibody‐mediated rejection was significantly more common (P < .001) in patients with dnDSA (61% vs 12%), in 53 (47%) patients that had at least one graft biopsy performed during follow‐up. dnDSA was a significant risk factor (odds ratio [OR] = 6.06; P = .003) for graft failure in a multivariable conditional logistic regression model. dnDSA as a time‐dependent variable, was also an independent predictor [hazard ratio (HR) = 2.46; P = .002] of graft failure in a multivariable Cox regression analysis. In both statistical approaches, only dnDSA‐II (OR = 11.90; P = .006) (HR = 2.30; P = .014) was significantly associated with graft failure. Post‐transplant dnDSA was clearly associated with graft loss, particularly if against HLA class II antigens. dnDSA detection should be a tool for post‐transplant monitoring of kidney graft recipients, allowing for the identification of those with a higher risk of graft failure.Keywords
This publication has 34 references indexed in Scilit:
- Pivotal Role of Complement-Fixing HLA Alloantibodies in Presensitized Kidney Allograft RecipientsAmerican Journal of Transplantation, 2006
- Transplantation across previously incompatible immunological barriersTransplant International, 2006
- Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine eraTransplant International, 2006
- Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney TransplantationJournal of the American Society of Nephrology, 2005
- Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantationTransplant International, 2005
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- Kidney graft failure and presensitization against HLA Class I and Class II antigens1Transplantation, 2002
- CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1Transplantation, 1996
- POSTTRANSPLANT ANTIDONOR LYMPHOCYTOTOXIC ANTIBODY PRODUCTION IN RELATION TO GRAFT OUTCOMETransplantation, 1987
- Significance of the Positive Crossmatch Test in Kidney TransplantationNew England Journal of Medicine, 1969